RSC Pharmaceutics Blog

We are delighted to introduce you to our new RSC Pharmaceutics Associate Editor, Professor Heidi Mansour.

Professor Mansour is currently a Professor and Program Leader of Drug Discovery and Delivery at the Florida International University (FIU) Center for Translational Science located in Port Saint Lucie, Florida, on the beautiful Treasure Coast.

“As an Associate Editor, I am delighted and honored to be a part of the expert team that serves the newly launched RSC Pharmaceutics. Having published in RSC journals, I am excited to promote this premier journal to our peers and scientific community. I look forward to RSC Pharmaceutics being a leading journal in the field.”

Read more about Professor Mansour here.

Read some of Professor Mansour’s research here:

Glycosylated Ang-(1-7) MasR Agonist Peptide Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles and Microparticles in Cognitive Impairment: Design, Particle Preparation, Physicochemical Characterization, and In Vitro Release
David Encinas-Basurto, John P. Konhilas, Robin Polt, Meredith Hay and Heidi M. Mansour
Pharmaceutics, 2022, 14, 587

Advanced design and development of nanoparticle/microparticle dual-drug combination lactose carrier-free dry powder inhalation aerosols
Priya Muralidharan, Evan K. Mallory, Monica Malapit, Hanna Phan, Julie G. Ledford, Don Hayes, Jr and Heidi M. Mansour
RSC Adv., 2020, 10, 41846-41856

Microparticulate/nanoparticulate powders of a novel Nrf2 activator and an aerosol performance enhancer for pulmonary delivery targeting the lung Nrf2/Keap-1 pathway
Priya Muralidharan, Don Hayes, Jr., Stephen M. Black and Heidi M. Mansour
Mol. Syst. Des. Eng., 2016, 1, 48-65

RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is now open for submissions.

Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.

Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.

We are delighted to introduce you to our new RSC Pharmaceutics Associate Editor Assaf Zinger.

Dr. Assaf Zinger is a leading researcher and educator specializing in nanomedicine and engineering. He is currently an Assistant Professor at the Technion-Israel Institute of Technology and an Adjunct Assistant Professor at the Houston Methodist Academic Institute in Texas, USA. Dr. Zinger’s research focuses on biomimetic nanoparticles, covering various fields from biochemical engineering, where he designs and tests these nanoparticles, to biomedical engineering, where he assesses their effectiveness against conditions like neurodegenerative diseases, brain injuries, and cancers.

“I was drawn to this journal because of its unwavering commitment to publishing ground breaking discoveries in pharmaceutical science and its awesome editorial board. I am hoping that publishing here will not be just about sharing your research; it will be about contributing to the future of medicine.”

Read more about Dr. Zinger here.

Read some of Dr Zinger’s research:

Unleashing the potential of cell biomimetic nanoparticles: Strategies and challenges in their design and fabrication for therapeutic applications
Assaf Zinger
J. Controlled Release, 2023, 358, 591-600

Enhancing Inflammation Targeting Using Tunable Leukocyte-Based Biomimetic Nanoparticles
Assaf Zinger, Manuela Sushnitha, Tomoyuki Naoi, Gherardo Baudo, Enrica De Rosa, Jenny Chang, Ennio Tasciotti and Francesca Taraballi
ACS Nano, 2021, 15, 6326-6339

RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is now open for submissions.

Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.

Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.

We are delighted to introduce you to our new RSC Pharmaceutics Associate Editor, Professor Xiaoxuan Liu.

Professor Xiaoxuan Liu is a Professor at the Center of Advanced Pharmaceuticals and Biomaterials in China Pharmaceutical University. Her research interest focuses on the development of novel dendrimer based nanosystems via modular self-assembling process for on-demand delivery of drugs and nucleic acid therapeutics in precision medicine.

Read more about Professor Liu here.

Read some of Professor Liu’s research here:

Cargo-selective and adaptive delivery of nucleic acid therapeutics by bola-amphiphilic dendrimers
Jiaxuan Chen, Dandan Zhu, Baoping Lian, Kangjie Shi, Peng Chen, Ying Li, Wenyi Lin, Ling Ding, Qiulin Long, Yang Wang, Erik Laurini, Wenjun Lan, Yun Li, Aura Tintaru, Caoyun Ju, Can Zhang, Sabrina Pricl, Juan Iovanna, Xiaoxuan Liu and Ling Peng
Proc. Natl. Acad. Sci. U.S.A., 2023, 120, e2220787120

A biodegradable amppnas.org/doi/10.1073/pnas.2220787120hiphilic poly(aminoester) dendrimer for safe and effective siRNA delivery
Chi Ma, Dandan Zhu, Wenyi Lin, Ying Li, Yuanzheng Huang, Huiling Zhu, Mengyun Ye, Yang Wang, Ling Peng and Xiaoxuan Liu
Chem. Commun., 2022, 58, 4168-4171

An amphiphilic dendrimer as a light-activable immunological adjuvant for in situ cancer vaccination
Yongchao Wang, Ningqiang Gong, Chi Ma, Yuxuan Zhang, Hong Tan, Guangchao Qing, Jimei Zhang, Yufei Wang, Jinjin Wang, Shizhu Chen, Xianlei Li, Qiankun Ni, Yuan Yuan, Yaling Gan, Junge Chen, Fangzhou Li, Jinchao Zhang, Caiwen Ou, Yongxiang Zhao, Xiaoxuan Liu and Xing-Jie Liang
Nat. Commun., 2021, 12, 4964

RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is now open for submissions.

Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.

Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.

We are delighted to introduce you to our RSC Pharmaceutics Associate Editor, Professor Clare Hoskins.

Professor Clare Hoskins is a Professor of Nanomedicine within the Department of Pure and Applied Chemistry, University of Strathclyde. Her research focusses on the development of various nanotechnology platforms for drug delivery and theranostics, with a special focus on cancer nanomedicine.

You can find out more about Professor Hoskins here.

RSC Pharmaceutics is a new gold open access journal leading the way in the field of Pharmaceutics. This journal publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. Read our full scope statement and submit your manuscript on our webpage.

Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.

Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.